- Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020
-
Obermair A, Beale P, Scott CL, Beshay V, Kichenadasse G, Simcock B, Nicklin J, Lee YC, Cohen P, Meniawy T
- KMID: 2526284
- J Gynecol Oncol.
- 2021 Nov;32(6):e95.
- doi: 10.3802/jgo.2021.32.e95
Epithelial ovarian cancer (EOC) is among the top ten causes of cancer deaths worldwide, and is one of the most lethal gynecological malignancies in high income countries, with incidence and... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study
-
Blinman P, Gainford C, Donoghoe M, Martyn J, Blomfield , Grant P, Kichenadasse G, Vaughan M, Brand A, Shannon C, Gebski V, Stockler M, Friedlander M
- KMID: 2177878
- J Gynecol Oncol.
- 2013 Oct;24(4):359-366.
- doi: 10.3802/jgo.2013.24.4.359
OBJECTIVE: Intraperitoneal (IP) chemotherapy in women with optimally debulked stage III ovarian cancer has been reported to prolong overall survival, but has not been widely adopted due to concerns about... -
- CITED
-
- Close
- SHARE
-
- Close
